Alice Lebreton

2.2k citations
31 papers · 1.7k indexed · h-index 22
Topics
RNA modifications and cancer (9 papers)RNA and protein synthesis mechanisms (9 papers)RNA Research and Splicing (9 papers)

In The Last Decade

Alice Lebreton

30 papers receiving 1.7k citations

Peers

Alice Lebreton
Comparison fields: 5 of 103
  • Molecular Biology 1.3k
  • Immunology 201
  • Biotechnology 199
  • Food Science 142
  • Oncology 140
Replace Jess H. Leber with:
Jess H. Leber United States
Andrea R. McWhorter Australia
Yves Laroche Belgium
Kosuke Murakami Japan
Kevin Barringer United States
Mauricio R. Terebiznik Canada
Richard A. Goldsby United States
Carsten Schwan Germany
Ángel Rivera-Calzada United Kingdom
Rachel Legendre France
Alice Lebreton relative to Jess H. Leber United States Jess H. Leber's profile →
Citations per field
00.5×2.5×
Jess H. Leber · 1×
Citations per year

Countries citing papers authored by Alice Lebreton

Since Specialization
Citations

This map shows the geographic impact of Alice Lebreton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Lebreton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Lebreton more than expected).

Fields of papers citing papers by Alice Lebreton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Lebreton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Lebreton. The network helps show where Alice Lebreton may publish in the future.

Co-authorship network of co-authors of Alice Lebreton

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Lebreton. A scholar is included among the top collaborators of Alice Lebreton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Lebreton. Alice Lebreton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 0
3 1
4 37
5 25
6 4
7 21
8 13
9 7
10 28
11 68
12 9
13 15
14 61
15 12
16 80
17 197
18 134
19 258
20 63

About Alice Lebreton

Alice Lebreton is a scholar working on Endocrinology, Biotechnology and Food Science, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), RNA and protein synthesis mechanisms (9 papers) and RNA Research and Splicing (9 papers). The work is most often cited by research in Biotechnology (199 citations), Molecular Biology (1.3k citations) and Endocrinology (82 citations). Alice Lebreton has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Pascale Cossart, Bertrand Séraphin, Alain Jacquier, Rafał Tomecki, Andrzej Dziembowski, Micheline Fromont‐Racine, Cosmin Saveanu, Hélène Bierne, Rajani Kanth Gudipati and Zhenyu Xu. Their work appears in journals such as Nature, Science and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026